Lori Firmani
Fortune : 26 990 $ au 31/07/2026
Fortune : 26 990 $ au 31/07/2026
Lori Firmani worked as Chief Financial & Accounting Officer at F-Star Therapeutics, Inc. in 2020.
Ms. Firmani worked as Chief Financial & Accounting Officer at Damora Therapeutics, Inc. from 2024 to 2026.
Ms. Firmani earned an MBA from Babson College and completed undergraduate studies at the State University of New York College at Geneseo.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/04/2026 | 931 ( 0% ) | 26 990 $ | 31/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Directeur Financier/CFO | 01/05/2026 |
| SPRING BANK PHARMACEUTICALS, INC. | Directeur Financier/CFO | 20/11/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Babson College
Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York College at Geneseo
State University of New York College at Geneseo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-Star Therapeutics, Inc. (United States)
F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Galecto, Inc.
Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national